Australia's largest stock trading and investment forum Australia's #1 stock forum

SUD

Click for more information

0.00%

4.2¢ suda pharmaceuticals ltd

Reading about the apparent array of shortcomings and lack of...

First 92 Last

Share
Profile

Follow
Ted1950

1,320 Posts.

133

08/12/18

11:48

Post #: 36792741
Share

Originally posted by Buckland ↑

What about the claim re - avoiding the need for costly effficacy

SUD-001 | Oral spray for migraine
§ SUD-001 is first oral spray of sumatriptan (GSK’s Imitrex® tablet) for rapid relief of migraine headache
§ Migraine market is approx $3.2 billion. Sumatriptan has 50% market share
§ Phase II study showed quicker onset of ac>on and less drug needed to achieve pain relief vs. Imitrex® tablet
§ Primary Market Research suggests prescribers & payers see important role for SUD-001 in pa>ents with nausea, GI problems or sudden onset headaches
§ Successful mee>ng with FDA in July 2015 regarding pivotal development plan - FDA accepted novel pharmacokinetic trial design, thus avoiding the need for costly efficacy studies prior to approval

Expand

Reading about the apparent array of shortcomings and lack of progress attributed to SC begs the question why he was voted in?

SUD Price at posting: 0.6¢ Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 22 more messages in this thread...

First 92 Last

Add SUD (ASX) to my watchlist